Delivery of Inhaled Medication to Children

References

• Warner J. Asthma: A follow up statement from an international paediatric asthma consensus group. Arch Dis Child 1992; 67: 240–248
   PubMed Web of Science ®Google Scholar
• Bisgaard H, Munck S L, Nielsen J P, Petersen W, Ohlsson S V. Inhaled budesonide for treatment of recurrent wheezing in early childhood. Lancet 1990; 336: 649–651
   PubMed Web of Science ®Google Scholar
• Noble V, Ruggins R, Everard M L, Milner A D. Inhaled budesonide for chronic wheezing under 18 months of age. Arch Dis Child 1992; 67: 285–288
   PubMed Web of Science ®Google Scholar
• Connett G J, Warde C, Wooler E, Lenney W. Use of budesonide in severe asthmatics aged 1–3 years. Arch Dis Child 1993; 69: 351–355
   PubMed Web of Science ®Google Scholar
• Everard M L, Hardy J G, Milner A D. Comparison of nebulised aerosol deposition in the lungs of healthy adults following oral and nasal inhalation. Thorax 1993; 48: 1045–1046
   PubMed Web of Science ®Google Scholar
• Chua H L, Collis G G, Newbury A M, Chan K, Bower G D, Sly P D, Le Souef P N. The influence of age on aerosol deposition in children with cystic fibrosis. Eur Respir J 1994; 7: 2185–2191
   PubMed Web of Science ®Google Scholar
• Becquemin M H, Swift D L, Bouchikhi A, Roy M, Teillac A. Particle deposition and resistance in the noses of adults and children. Eur Respir J 1991; 4: 694–702
   PubMed Web of Science ®Google Scholar
• Olsson B. Aerosol particle generation from dry powder inhalers; Can they equal pressurized metered dose inhalers. J Aerosol Med 1995; 8: S13–18
   PubMedGoogle Scholar
• O'Doherty M J, Thomas S HL, Gibb D, Page C J, Harrington C, Duggan C, Nunan T O, Bateman N T. Lung deposition of nebulised pentamidine in children. Thorax 1993; 48: 220–226
   PubMed Web of Science ®Google Scholar
• Tal A, Golan H, Grauer N, Aviram M, Albin D, Quastel M R. Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction. J Pediatr 1996; 328: 479–484
   Google Scholar
• Everard M L, Devadason S G, Macerlean C, Roller C, Summers O, Swift P, Borgstrom L, Le Souef P N. Drug delivery from turbuhaler to children with cystic fibrosis. Am J Respir Crit Care Med 1996; 253(4)A70
   Google Scholar
• Thomas S HL, Batchelor S, O'Doherty M J. Therapeutic aerosols in children. Br Med J 1993; 307: 245–247
   PubMedGoogle Scholar
• Everard M L. Studies using radiolabeled aerosols in children. Thorax 1994; 49: 1259–1266
   PubMedGoogle Scholar
• Salmon B, Wilson N M, Silverman M. How much aerosol reaches the lungs of wheezy infants and toddlers. Arch Dis Child 1990; 65: 401–103
   PubMed Web of Science ®Google Scholar
• Hindle M, Chrystyn H. Determination of the relative bioavailability of salbutamol to the lung following inhalation. Br J Clin Pharmacol 1992; 34: 311–315
   PubMed Web of Science ®Google Scholar
• Borgström L, Nilsson M. A method for determination of the absolute pulmonary bioavailability of inhaled drugs; Terbutaline. Pharm Res 1990; 7: 1068–1070
   PubMed Web of Science ®Google Scholar
• Thorsson L, Edsbäcker S, Conradson T B. Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered dose inhaler P-MDI. Eur Respir J 1994; 7: 1839–1844
   PubMed Web of Science ®Google Scholar
• Lippmann M, Yeates D B, Albert R E. Deposition, retention and clearance of inhaled particles. Br J Ind Med 1980; 37: 337–362
   PubMedGoogle Scholar
• Gonda I. semi-empirical model of aerosol deposition in the human respiratory tract for mouth inhalation. J Pharm Pharmacol 1981; 33: 692–696
   PubMed Web of Science ®Google Scholar
• Heyder J. Alveolar deposition of inhaled particles in humans. Am hid Hyg Assoc J 1982; 43: 864–866
   PubMed Web of Science ®Google Scholar
• Stahlhofen W, Rudolf G, James A C. Intercomparison of experimental regional aerosol deposition data. J Aerosol Med 1989; 2: 285–308
   Google Scholar
• Agnew J E. Characterizing lung aerosol penetration. J Aerosol Med 1991; 4: 237–249
   Google Scholar
• Martonen T B, Katz I. Deposition patterns of polydis-perse aerosols within human lungs. J Aerosol Med 1993; 6: 251–274
   Google Scholar
• Perring S, Summers Q, Fleming J S, Nassim M A, Holgate S T. new method of quantification of the pulmonary regional distribution of aerosols using combined CT and SPECT and its application to nedocromil sodium administered by metered dose inhaler. Br J Radiol 1994; 67: 46–53
   PubMed Web of Science ®Google Scholar
• Holgate S T, Fleming J S, Conway J, Hashish A H, Nassim M A, Halson P, Moore E, Bailey A G. Assessment of deposition of inhaled aerosol in the respiratory tract of man using three dimensional mul-timodality imaging and mathematical modelling. Respiratory Drug Delivery V, R N Dalby, P R Byron, S Y Farr. Interpharm Press, Phoenix, AZ, Buffalo Grove, IL 1996; 1–10
   Google Scholar
• Task Group on Lung Dynamics. Deposition and retention models for internal dosimetry of the human respiratory tract. Health Phys 1966; 22: 173–208
   Google Scholar
• Agnew J E. Bronchiolar aerosol deposition and clearance. Eur Respir J 1996; 9: 1118–1122
   PubMedGoogle Scholar
• Persson G, Wiren J E. The bronchodilator response from inhaled terbutaline is influenced by the mass of small particles; a study on a dry powder inhaler (Turbuhaler). Eur Respir J 1989; 2: 253–256
   PubMed Web of Science ®Google Scholar
• Rees P J, Clark T JH, Moren F. The importance of particle size response to inhaled bronchodilators. Eur J Respir Dis 1982; 63: 73–8
   PubMedGoogle Scholar
• Clay M M, Pavia D, Clarke S W. Effect of aerosol particle size on bronchodilatation with nebulised terbutaline in asthmatic subjects. Thorax 1986; 42: 364–368
   Google Scholar
• Clay M M, Clarke S W. Effect of nebulised aerosol size on lung deposition in patients with mild asthma. Thorax 1987; 42: 190–194
   PubMedGoogle Scholar
• Johnson M A, Newman S P, Bloom R, Talaee N, Clarke S W. Delivery of albuterol and ipratropium bromide from two nebuliser systems in chronic stable asthma. Chest 1989; 96: 1–10
   PubMedGoogle Scholar
• Borgstöm L, Derom E, Stahl E, Wahlin-Boll E, Pauwels R. The inhalation device influences lung deposition and bronchodilating effect of terbutaline. Am J Respir Crit Care Med 1996; 253: 1636–1640
   Google Scholar
• Zanen P, Go L T, Lammers J WJ. The optimal particle size for beta-adrenergic aerosols in mild asthmatics. Int J Pharm 1994; 207: 211–217
   Google Scholar
• Patel P, Mukai D, Wilson A F. Dose-response effects of two sizes of monodisperse isoproterenol in mild asthma. Am Rev Respir Dis 1990; 242: 357–360
   Google Scholar
• Dolovich M, Ryan G, Newhouse M T. Aerosol penetration into the lung. Chest 1981; 80: 834, Suppl
   PubMedGoogle Scholar
• Mitchell D M, Solomon M A, Tolfree S EJ, Short M, Spiro S G. Effect of particle size of bronchodilator aerosols on lung distribution and pulmonary function in patients with chronic asthma. Thorax 1987; 42: 457–461
   PubMedGoogle Scholar
• Zainudin B MZ, Tolfree S EJ, Short M, Spiro S G. Influence of breathing pattern on lung deposition and bronchodilator response to nebulised salbuta-mol in patients with stable asthma. Thorax 1988; 43: 987–991
   PubMedGoogle Scholar
• Olsson B, Borgström L, Asking L, Bondesson E. Effect of inlet throat on the correlation between measured fine particle dose and lung deposition. Respiratory Drug Delivery V, R N Dalby, P R Byron, S Y Farr. Interpharm Press, Phoenix AZ Buffalo Grove, IL 1996; 273–281
   Google Scholar
• Berg E. Dose characterization from a pMDI and a new spacer with and without a cast of the throat of a child. Respiratory Drug Delivery V, R N Dalby, P R Byron, S Y Farr. Interpharm Press, Phoenix AZ Buffalo Grove, IL 1996; 308–309
   Google Scholar
• Bisgaard H, Berg E. Cast of human airways from the lips to the trachea for in vitro estimate of lung dose. Eur Respir J 1997; 10: 236
   Google Scholar
• Bisgaard H. Drug delivery from inhaler devices. Br Med J 1996; 323: 895–896
   Google Scholar
• Derom E, Pauwels R. Bioequivalence of inhaled drugs. Eur Respir J 1995; 8: 1634–1636
   PubMedGoogle Scholar
• Rogers D F, Ganderton D. Determining equivalence of inhaled medications. Consensus statement from a workshop of the British Association for Lung Research. Respir Med 1995; 89: 253–261
   PubMedGoogle Scholar
• Blake K V, Harman E, Hendeles L. Evaluation of a generic albuterol metered-dose inhaler. Importance of priming the MDI. Ann Allergy 1992; 68: 169–174
   PubMedGoogle Scholar
• Miller M R, Bright P. Differences in output from corticosteroid inhalers used with a volumatic spacer. Eur Respir J 1995; 8: 1637–1638
   PubMedGoogle Scholar
• Kenyon C J, Dewsbury N J, Newman S P. Differences in aerodynamic particle size distributions of innovator and generic beclomethasone dipropionate aerosols used with and without a large volume spacer. Thorax 1995; 50: 846–850
   PubMedGoogle Scholar
• Pierce A K, Sandford J P, Thomas G D, Leonard J S. Long-term evaluation of decontamination of inhalation therapy equipment and occurrence of necrotizing pneumonia. N Engl J Med 1970; 282: 528–531
   PubMed Web of Science ®Google Scholar
• Barnes K L, Clifford R, Holgate S T, Murphy D, Comber P, Bell E. Bacterial contamination of home nebulisers. Br Med J 1987; 295: 812
   PubMed Web of Science ®Google Scholar
• Pedersen S. Inhaler use in children with asthma. Danish Med Bull 1987; 34: 234–249
   PubMed Web of Science ®Google Scholar
• Pedersen S. Inhalers and nebulizers; Which to choose and why. Respir Med 1996; 90: 69–77
   PubMed Web of Science ®Google Scholar
• Newman S P. Metered dose pressurized aerosols and the ozone layer. Eur Respir J 1990; 3: 495–497
   PubMed Web of Science ®Google Scholar
• Balmes J R. The environmental impact of chlorofluo-rocarbon use in metered dose inhalers. Chest 1991; 200: 1101–1102
   Google Scholar
• Pavia D, McLeod L. The environmental impact of inhaled aerosols. Eur Respir Rev 1994; 4: 75–77
   Google Scholar
• D'Souza S. The Montreal Protocol and essential use exemptions. J Aerosol Med 1995; 8: S13–17
   PubMedGoogle Scholar
• Isaksen I SA. Dual effects otozone reduction. Nature 1994; 372: 322–323
   Google Scholar
• Smith R. Doctors and climatic change. Br Med J 1994; 309: 1384–1385
   PubMedGoogle Scholar
• Hileman B. Scientists warn that disease threats increase as earth warms up. C & EN 1995; 2: 19–20
   Google Scholar
• Marshall L M, Francis P W, Khafagi F A. Aerosol deposition in cystic fibrosis using an aerosol conservation device and a conventional jet nebulizer. J Paediatr Child Health 1994; 30: 65–67
   PubMedGoogle Scholar
• Mukhopadhyay S, Staddon G E, Estman C, Palmer M, Rhys Davies E, Carswell F. The quantitative distribution of nebulized antibiotics in the lung in cystic fibrosis. Respir Med 1994; 88: 203–211
   PubMed Web of Science ®Google Scholar
• Thomas S HL, O'Doherty M J, Page C J, Nunan T O, Bateman N T. Which apparatus for inhaled pentamidine? A comparison of pulmonary deposition via eight nebulisers. Eur Respir J 1991; 4: 616–622
   PubMedGoogle Scholar
• Lewis R A, Fleming J S. Fractional deposition from a jet nebulizer; How it differs from a metered dose inhaler. Br J Dis Chest 1985; 79: 361–367
   PubMedGoogle Scholar
• Zainudin B MZ, Biddiscombe M, Tolfree S EJ, Short M, Spiro S G. Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurised metered dose inhaler, as a dry powder, and as a nebulised solution. Thorax 1990; 45: 469–473
   PubMed Web of Science ®Google Scholar
• Collis G, Cole C H, Le Souef P N. Dilution of nebulised aerosols by air entrainment in children. Lancet 1990; 336: 341–343
   PubMed Web of Science ®Google Scholar
• Smith E C, Denyer J, Kendrick A H. Comparison of twenty three nebulizer/compressor combinations for domiciliary use. Eur Respir 1995; 8: 1214–1221
   PubMed Web of Science ®Google Scholar
• Clay M M, Pavia D, Newman S P, Lennard-Jones T, Clarke S W. Assessment of jet-nebulisers for lung aerosol therapy. Lancet 1983; 2: 592–594
   PubMed Web of Science ®Google Scholar
• Newman S P, Pellow P GD, Clay M M, Clarke W S. Evaluation of jet nebulisers for use with gentamicin solution. Thorax 1985; 40: 671–676
   PubMed Web of Science ®Google Scholar
• Phipps P R, Gonda I. Droplets produced by medical nebulizers. Chest 1990; 97: 1327–1332
   PubMed Web of Science ®Google Scholar
• Brockbank W, Brebner H, Pengelly C DR. Chronic asthma treated with aerosol hydrocortisone. Lancet 1956; 2: 807
   Google Scholar
• Morrison Smith J. Hydrocortisone hemisuccinate by inhalation in children with asthma. Lancet 1958; 2: 1248–1249
   PubMedGoogle Scholar
• O'Callaghan C. Particle size of beclomethasone dipro-pionate produced by two nebulisers and two spacing devices. Thorax 1990; 45: 109–111
   PubMedGoogle Scholar
• Webb M SC, Milner A D, Hiller E J, Henry R L. Nebulised beclomethasone dipropionate suspension. Arch Dis Child 1986; 67: 1108–1110
   Google Scholar
• Storr J, Lenney C A, Lenney W. Nebulised beclomethasone dipropionate in preschool asthma. Arch Dis Child 1986; 62: 270–273
   Google Scholar
• Bisgaard H, Nikander K, Munch E. Comparative study of budesonide as a nebulized suspension versus pressurized metered dose inhaler in adult asthmatics. Respir Med, 92, in press
   PubMedGoogle Scholar
• Bisgaard H. Aerosol treatment of young children. Eur Respir Rev 1994; 4: 15–20
   Google Scholar
• Schöni MH, Kraemer R. Osmolality changes in neb-uliser solutions. Eur Respir J 1989; 2: 887–892
   PubMedGoogle Scholar
• O'Callaghan C, Milner A D, Swarbrick A. Paradoxical deterioration in lung function after nebulized salbutamol in wheezy infants. Lancet 1986; 2: 1424–1425
   PubMed Web of Science ®Google Scholar
• O'Callaghan C, Milner A D, Swarbrick A. Paradoxical bronchoconstriction in wheezing infants after nebulised preservative free iso-osmolar ipratropium bromide. Br Med J 1989; 299: 1433–1434
   PubMed Web of Science ®Google Scholar
• Cochetto D, Sykes R S, Spector S. Paradoxical bron-chospasm after use of inhalation aerosols; A review of the literature. J Asthma 1991; 28: 49–53
   PubMedGoogle Scholar
• Dolovich M B, Ruffin R E, Roberts R, Newhouse M T. Optimal delivery of aerosols from metered dose inhalers. Chest 1981; 80: 911–915, Suppl
   PubMed Web of Science ®Google Scholar
• Newman S P, Pavia D, Moren F, Sheahan N F, Clarke S W. Deposition of pressurised aerosols in the human respiratory tract. Thorax 1981; 36: 52–55
   PubMed Web of Science ®Google Scholar
• Melchor R, Biddiscombe M F, Mak V HF, Short M D, Spiro S G. Lung deposition patterns of directly labeled salbutamol in normal subjects and in patients with reversible airflow obstruction. Thorax 1993; 48: 506–511
   PubMed Web of Science ®Google Scholar
• Matthys H, Eltschka R, App E M. Deposition of a labeled beta2-agonist aerosol. Atemwlungenkrkn 1988; 10: 485–488
   Google Scholar
• Farr S J, Rowe A M, Rubsamen R, Taylor G. Aerosol deposition in the human lung following administration from a microprocessor controlled pressurised metered dose inhaler. Thorax 1995; 50: 639–644
   PubMed Web of Science ®Google Scholar
• King D, Earnshaw S M, Delaney J C. Pressurised aerosol inhalers; The cost of misuse. Br J Gen Pract 1991; 45: 48–19
   Google Scholar
• Byron P R. Dosing reproducibility from experimental albuterol suspension metered-dose inhalers. Pharm Res 1994; 22: 580–584
   Google Scholar
• Pedersen S. Aerosol treatment of bronchoconstriction in children with or without a tube spacer. N Engl J Med 1983; 308: 1328–1330
   PubMed Web of Science ®Google Scholar
• Pedersen S, østergaard P A. Nasal inhalation as a cause of inefficient pulmonary aerosol inhalation technique in children. Allergy 1983; 38: 191–194
   PubMedGoogle Scholar
• Pedersen S, Frost L, Arnfred T. Errors in inhalation technique and efficiency in inhaler use in asthmatic children. Allergy 1986; 42: 118–124
   Google Scholar
• Goodman D E, Israel E, Rosenberg M, Johnston R, Weiss S T, Drazen J M. The influence of age, diagnosis and gender on proper use of metered-dose inhalers. Am J Respir Crii Care Med 1994; 250: 1256–1261
   Google Scholar
• Thompson J, Irvine T, Grathwohl K, Roth B. Misuse of metered-dose inhalers in hospitalized patients. Chest 1994; 105: 715–717
   PubMed Web of Science ®Google Scholar
• Hilton S. An audit of inhaler technique among asthma patients of 34 general practitioners. Br J Gen Pract 1990; 40: 505–506
   PubMed Web of Science ®Google Scholar
• Guidry G G, Brown W D, Stogner S W, George R B. Incorrect use of metered dose inhalers by medical personnel. Chest 1992; 101: 31–33
   PubMed Web of Science ®Google Scholar
• Ruggins N R, Milner A D, Swarbrick A. An Assessment of a new breath actuated inhaler device in acutely ill wheezy children. Arch Dis Child 1993; 68: 477–180
   PubMed Web of Science ®Google Scholar
• Newman S P, Weisz A W, Talaee N, Clarke S W. Improvement of drug delivery with a breath actuated pressurized aerosol for patients with poor inhaler technique. Thorax 1991; 46: 712–716
   PubMed Web of Science ®Google Scholar
• Leach C. Enhanced drug delivery through reformulating MDIs with HFA propellants-drug deposition and its effect on preclinical and clinical programs. Respiratory Drug Delivery V, R N Dalby, P R Byron, S Y Farr. Interpharm Press, Phoenix, AZ, Buffalo Grove, IL 1996; 133–144
   Google Scholar
• Clark D J, Lipworth B J. Lung bioavailability of chlo-rofluorocarbon free, dry powder and chlorofluoro-carbon containing formulations of salbutamol. Br J Clin Pharmacol 1996; 42: 247–249
   Google Scholar
• Hampson N B, Mueller M P. Cooling of metered-dose inhalers decreases pressure output from cannisters. N Engl J Med 1989; 320: 321
   PubMedGoogle Scholar
• Everard M L, Devadason S G, Summers Q A, Le Souef P N. Factors affecting total and “respirable” dose delivered by a salbutamol metered dose inhaler. Thorax 1995; 50: 746–749
   PubMed Web of Science ®Google Scholar
• Cyr T D, Graham S J, Li R KY, Lovering E G. Low first-spray drug content in albuterol metered-dose inhalers. Pharm Res 1991; 8: 658–660
   PubMed Web of Science ®Google Scholar
• Borgström L. Methodological studies on lung deposition. Evaluation of inhalation devices and absorption mechanisms. Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 705. Acta Univ Uppsala, Uppsala 1993; 1–51
   Google Scholar
• Newman S P. Deposition and effects of inhalation aerosols. Thesis. Rahms Tryckeri, Lund 1983
   Google Scholar
• Graff-Lonnevig V. Diurnal expiratory flow after inhalation of freons and fenoterol in childhood asthma. J Allergy Clin Immunol 1979; 64: 534–538
   PubMed Web of Science ®Google Scholar
• Yarborough J, Mansfield L E, Ting S. Metered dose inhaler induced bronchospasm in asthmatic patients. Ann Allergy 1985; 55: 25–27
   PubMedGoogle Scholar
• Nicklas R A. Paradoxical bronchospasm associated with the use of inhaled beta-agonists. J Allergy Clin Immunol 1990; 85: 959–964
   PubMedGoogle Scholar
• Engel T. Patient-related side effects of CFC propellents. J Aerosol Med 1991; 3: 163–167
   Google Scholar
• Wilkinson J RW, Roberts J A, Bradding P, Holgate S T, Howarth P H. Paradoxical bronchoconstriction in asthmatic patients after salmeterol by metered dose inhaler. Br Med J 1992; 305: 931–932
   PubMedGoogle Scholar
• Jackson L, Ståhl E, Holgate S T. Terbutaline via pressurised metered dose inhaler (pMDI) and Turbuhaler in highly reactive asthmatic patients. Eur Respir J 1994; 7: 1598–1601
   PubMedGoogle Scholar
• Selroos O, Lofroos A B, Pietinalho A, Riska H. Comparison of terbutaline and placebo from a pressurised metered dose inhaler and a dry powder inhaler in a subgroup of patients with asthma. Thorax 1994; 49: 1228–1230
   PubMedGoogle Scholar
• Shaheen M Z, Ayres J G, Benincasa C. Incidence of acute decreases in peak expiratory flow following the use of metered-dose inhalers in asthmatic patients. Eur Respir J 1994; 7: 2160–2164
   PubMedGoogle Scholar
• Williams D], Williams A C, Kruchek D G. Problems in assessing contents of metered dose inhalers. Br Med 1993; 1307: 771–772
   Google Scholar
• Newman S, Millar A B, Lennard-Jones T R, Moren F, Clarke S. Improvement of pressurised aerosol deposition with Nebuhaler spacer device. Thorax 1984; 39: 935–941
   PubMed Web of Science ®Google Scholar
• Newman S P, Steed K, Hooper G, Kallen A, Borgstrom L. Comparison of gamma scintigraphy and a pharmacokinetic technique for assessing pulmonary deposition of terbutaline sulphate delivered by pressurized metered dose inhaler. Pharm Res 1995; 12: 231–236
   PubMed Web of Science ®Google Scholar
• Vidgren P, Vidgren M, Paronen P, Vainio P, Nuutinen J. Effects of inspirease holding chamber on the deposition of metered dose inhalation aerosols. Eur J Drug Metab Pharmacokinet 1991, Spec No 3: 419–425
   PubMedGoogle Scholar
• Bisgaard H. Dose of aerosol inhaled in young children from a small-volume spacer. Eur J Respir Dis 1993; 6: 352
   Google Scholar
• Bisgaard H. metal aerosol holding chamber devised for young children with asthma. Eur Respir J 1995; 8: 856–860
   PubMedGoogle Scholar
• Bisgaard H, Anhøj J, Klug B, Berg E. non-electrostatic spacer for aerosol delivery. Arch Dis Child 1995; 73: 226–230
   PubMed Web of Science ®Google Scholar
• O'Callaghan C, Lynch J, Cant M, Robertson C. Improvement in sodium cromoglycate delivery from a spacer device by use of antistatic lining, immediate inhalation, and avoiding multiple actuations of drug. Thorax 1993; 48: 603–606
   PubMed Web of Science ®Google Scholar
• Barry P W, O'Callaghan C. The effect of delay, multiple actuations and spacer static charge on the in vitro delivery of budesonide from the Nebuhaler. Br J Clin Pharmacol 1995; 40: 76–78
   PubMed Web of Science ®Google Scholar
• Fuglsang G, Pedersen S. Cumulative dose response relationship of terbutaline delivered by three different inhalers. Allergy 1988; 43: 348–352
   PubMedGoogle Scholar
• Hindle M, Chrystyn H. Nebuhaler and volumatic improve pulmonary delivery. Arch Dis Child 1992; 67: 580–585
   PubMedGoogle Scholar
• Kraemer R, Frey U, Sommer C W, Russi E. Short-term effect of albuterol, delivered via a new auxiliary device in wheezy infants. Am Rev Respir Dis 1991; 744: 347–351
   Google Scholar
• Franklin W, Lowell F C, Michelson A L, Schiller I W. Aerosolized steroids in bronchial asthma. J Allergy 1958; 29: 214–221
   PubMedGoogle Scholar
• Kenyon C J, Thorsson L, Borgström L, Newman S P. The effects of static charge in spacer devices on gluco-corticosteroid aersol deposition in asthmatic patients. Eur Respir J 1997, in press
   Google Scholar
• Moren F. Drug deposition of pressurized inhalation aerosols. Influence of actuator tube design. Int J Pharm 1978; 2: 205–212
   Google Scholar
• Bisgaard H, Berg E, Madsen J. Dose delivery and fine particle dose of aerosol from three spacers intended for asthma treatment in young children. Eur Respir J 1996; 9: 431S, Suppl 23
   PubMedGoogle Scholar
• Wildhaber J H, Devadason S G, Hayden M J, James R, Dufty A P, Fox R A, Summers Q A, LeSouef P N. Electrostatic charge on a plastic spacer device influences the delivery of salbutamol. Eur Respir J 1996; 9: 1943–1946
   PubMed Web of Science ®Google Scholar
• Matthys H. Inhalation delivery of asthma drugs. Lung 1990; 168: 645–652
   PubMed Web of Science ®Google Scholar
• Fields M R. US Patent. 2470296, 1946
   Google Scholar
• Herxheimer H, McAllen M K, Williams D A. Local treatment of bronchial asthma with hydrocortisone powder. Br Med J 1958; 2: 762–765
   PubMedGoogle Scholar
• Helm W B, Hey worth F. Bronchial asthma and chronic bronchitis treated with hydrocortisone acetate inhalations. Br Med J 1958; 1: 765–768
   PubMedGoogle Scholar
• Thorsson L, Dahlström K, Edsbäcker S, Källén A, Paulson J, Wirén J-E. Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects. Br J Clin Pharmacol 1997; 43: 155–161
   PubMed Web of Science ®Google Scholar
• Bisgaard H, Andersen J B, Mortensen N B, Bertelsen A, Friis B, Koch C, Prahl P, Wickmann R, østerballe O. clinical comparison of aerosol and powder administration of beclomethasone dipropionate in childhood asthma. Allergy 1984; 39: 365–369
   PubMedGoogle Scholar
• Borgström L, Newman S. Total and regional lung deposition of terbutaline sulphate inhaled via a pressurised MDI or via Turbuhaler. Int J Pharm 1993; 97: 47–53
   Google Scholar
• Borgström L, Newman S P, Weisz A, Moren F. Pulmonary deposition of inhaled terbutaline: Comparison of scanning gamma camera and urinary excretion methods. J Pharm Sci 1992; 81: 753–755
   PubMed Web of Science ®Google Scholar
• Ekström T, Andersson A-C, Skedinger M, Lindbladh C, Stahl E. Dose potency relationship of terbutaline inhaled via Turbuhaler or via a pressurized metered dose inhaler. Ann Allergy 1995; 74: 328–332
   Google Scholar
• Löfdahl CG, Andersson L, Bondesson E, Carlsson L G, Friberg K, Homblad Y, Jemsby P, Rosenborg J, Werner S, Svedmyr N. Salbutamol doses inhaled via Turbuhaler gives a better bronchodilating effect than when given via a pressurized metered dose inhaler. Eur Respir J 1994; 7: 49s
   Google Scholar
• Matusiewicz S P, Bollert F G, Dewar M, Brown G, McLean A, Greening A P, Crompton G K. Ipratropium bromide given by Turbohaler is more potent than when given by pressurised dose inhaler (MDI). Thorax 1995; 50: 469P
   Google Scholar
• Agertoft L, Pedersen S. Importance of the inhalation device on the effect of budesonide. Arch Dis Child 1993; 69: 130–133
   PubMed Web of Science ®Google Scholar
• Hultquist C, Ahlström H, Kjellman N IM, Malmqvist L-Å, Svenonius E, Melin S. double-blind comparison between a new multiple dose powder inhaler (Turbuhaler) and metered-dose inhaler in children with asthma. Allergy 1989; 44: 467–470
   PubMedGoogle Scholar
• Osterman K, Norborg A M, Stähl E. multiple dose powder inhaler (Turbuhaler) compared with a conventional aerosol. Allergy 1989; 44: 294–297
   PubMedGoogle Scholar
• Svenonius E, Arborelius M, Wiberg R, Stahl E, Svensson M. comparison of terbutaline inhaled by Turbuhaler and by chlorofluorocarbon (CFC) inhaler in children with exercise-induced asthma. Allergy 1994; 49: 408–412
   PubMed Web of Science ®Google Scholar
• Johnsen C R, Weeke E R. Turbuhaler; a new device for dry powder terbutaline inhalation. Allergy 1988; 43: 392–395
   PubMedGoogle Scholar
• Svartengren K, Lindestad P-Å, Svartengren M, Philipson K, Bylin G, Camner P. Added external resistance reduces oropharyngeal deposition and increases lung deposition of aerosol particles in asthmatics. Am J Respir Crit Care Med 1995; 152: 32–37
   PubMed Web of Science ®Google Scholar
• Bisgaard H, Klug P KP, Burnell P, Sumby B S. Use of inhalation profiles from paediatric asthmatics using the diskus and turbuhaler inhalers to evaluate product performance in-vitro. Am J Respir Crit Care Med 1996; 153(4)A75
   Google Scholar
• Hindle M, Byron P R. Dose emission from marketed dry powder inhalers. Hit J Pharm 1994; 36: 1–9
   Google Scholar
• Meakin B J, Cainey J M, Woodcock P M. Drug delivery characteristics of Bricanyl Turbuhaler dry powder inhalers. Hit J Pharm 1995; 239: 91–102
   Google Scholar
• Olsson B, Asking L. Critical aspects of the function of inspiratory flow driven inhalers. J Aerosol Med 1994; 7: S43–47
   PubMedGoogle Scholar
• Brindley A, Sumby B S, Smith I J. The characterisation of inhalation devices by an inhalation simulator: the electronic lung. J Aerosol Med 1994; 7: 197–200
   PubMedGoogle Scholar
• Bisgaard H, Pedersen S, Nikander K. Use of budesonide Turbuhaler in young children suspected of asthma. Eur Respir J 1994; 7: 740–742
   PubMedGoogle Scholar
• Newman S P, Morén F, Trofast E, Talaee N, Clarke S W. Terbutaline sulphate Turbuhaler; Effect of inhaled flow rate on drug deposition and efficacy. Int Pharm 1991; 74: 209–213
   Web of Science ®Google Scholar
• Newman S P, Hollingworth A, Clark A R. Effect of different modes of inhalation on drug delivery from a dry powder inhaler. Int J Pharm 1994; 302: 127–132
   Google Scholar
• Borgström L, Bondesson E, Moren F, Trofast E, Newman S P. Lung deposition of budesonide inhaled via Turbuhaler. A comparison with terbutaline sulphate in normal subjects. Eur Respir J 1994; 7: 69–73
   PubMed Web of Science ®Google Scholar
• Pedersen S, Hansen O R, Fuglsang G. Influence of inspiratory flow rate upon the effect of a Turbuhaler. Arch Dis Child 1990; 65: 308–310
   PubMed Web of Science ®Google Scholar
• Engel T, Scharling B, Skovsted B, Heinig ]H. Effects, side effects and plasma concentrations of terbutaline in adult asthmatics after inhaling from dry powder inhaler device at different inhalations and flows and volumes. Br J Clin Pharmacol 1992; 33: 439–444
   PubMedGoogle Scholar
• Richards R, Dickson C R, Renwick A G, Lewis R A, Holgate S T. Absorption and disposition kinetics of cromolyn sodium and the influence of inhalation technique. J Pharmacol Exp Titer 1987; 243: 1028–1032
   Google Scholar
• Auty R M, Brown K, Neale M G, Snashall P D. Respiratory tract deposition of sodium cromoglycate is highly dependent upon technique of inhalation using the Spinhaler. Br J Dis Chest 1987; 83: 371–380
   Google Scholar
• Nielsen K G, Skov M, Klug B, Ifversen M, Bisgaard H. Flow dependent effect of the formoterol dry powder inhaler. Eur Respir J 1996; 9: 432s
   Google Scholar
• Nielsen K G, Auk I L, Bojsen K, Bisgaard H. Effects of salmeterol 5 micg inhaled at high and low flow rates from a Diskus Inhaler. Eur Respir J 1996; 9: 287s
   Google Scholar
• Borgström L, Asking L, Beckman O, Bondesson E, Kallen A, Olsson B. Dose variation within and between individuals, with different inhalation systems. Respiratory Drug Delivery V, R N Dalby, P R Byron, S Y Farr. Interpharm Press, Phoenix AZ Buffalo Grove, IL 1996; 19–24
   Google Scholar
• Laberge S, Spier S, Drblik S P, Turgeon J P. Comparison of inhaled terbutaline administered by either Turbuhaler dry powder inhaler or a metered-dose inhaler with spacer in preschool children with asthma. J Pediatr 1994; 124: 815–817
   PubMed Web of Science ®Google Scholar
• Goren A, Noviski N, Avital A, Maavan C, Stahl E, Godfrey S, Springer C. Assessment of the ability of young children to use a powder inhaler device (Turbuhaler). Pediatr Pulmonol 1994; 18: 77–80
   PubMed Web of Science ®Google Scholar
• Pendergast J, Hopkins J, Timms B, Van Asperen P P. Comparative efficacy of terbutaline administered by Nebuhaler and by nebulizer in young children with acute asthma. Med J Aust 1989; 252: 406–108
   Google Scholar
• Lin Y Z, Hsieh K H. Metered dose inhaler and nebu-liser in acute asthma. Arch Dis Child 1995; 72: 214–218
   PubMed Web of Science ®Google Scholar
• Newman S P, Steed K P, Reader S J, Hooper G, Zierenberg B. Efficient delivery to the lungs of flunisolide from a portable hand-held multidose nebulizer. J Plmrm Sci 1996; 85: 960–964
   Google Scholar
• Gupte A R, Hochrainer D, Poss G, Wittekind J, Zierenberg B, Knecht A. Patent application. WO 92/00115, 1992
   Google Scholar
• Galli R. Patent application WO. 93/18812, 1993
   Google Scholar
• Bruna P, Pourment O, Williams G. In-vitro characterisation of a new dry powder inhaler, the Prohaler, with two hydrophilic drugs in normal and humid conditions. Respiratory Drug Delivery IV, P Byron, R N Dalby, S J Farr. Interpharm Press, Buffalo Grove, IL 1994; 352–354
   Google Scholar
• Jäger-Waldau R, Mehring H, Wiggins J D. Feasibility of a low dosage dynamic powder dispenser for drug delivery to the lungs. J Aerosol Med 1994; 7: 205–208
   PubMedGoogle Scholar
• Micikalski M B, Williams D R. Patent application WO. 94/08552, 1994
   Google Scholar
• Hill M. Characteristics of an active multiple dose dry powder inhaler. Respiratory Drug Delivery IV, P Byron, R N Dalby, S J Farr. Interpharm Press, Buffalo Grove, IL 1994; 109–116
   Google Scholar
• Schultz R K, Miller N C, Smith D K, Ross D L. Powder aerosols with auxiliary means of dispersion. J Biopharm Sci 1992; 3: 115–121
   Google Scholar
• Bisgaard H. European Patent no. EP548152
   Google Scholar